Cintia Piccina
Corporate Officer/Principal at ADAPTIMMUNE THERAPEUTICS PLC
Net worth: 175 231 $ as of 30/04/2024
Profile
Cintia Piccina is currently the Chief Commercial Officer at Adaptimmune Therapeutics Plc.
She started this position in 2024.
Prior to her current role, she held the same position at Adaptimmune Therapeutics Plc from 2022 to 2023.
Cintia also has experience as the SVP-Commercial Oncology & US General Manager at 2seventy Bio, Inc. and as the Chief Commercial Officer at AlloVir, Inc. In terms of education, Dr. Piccina holds a doctorate degree from the University of Sao Paulo and an MBA from Escola Superior de Propaganda e Marketing.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALLOVIR INC
0.13% | 03/07/2023 | 147,000 ( 0.13% ) | 117 600 $ | 30/04/2024 |
| 01/04/2024 | 326,154 ( 0.06% ) | 57 631 $ | 30/04/2024 |
Cintia Piccina active positions
| Companies | Position | Start |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 18/03/2024 |
Former positions of Cintia Piccina
| Companies | Position | End |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 05/03/2023 |
| ALLOVIR, INC. | Corporate Officer/Principal | - |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - |
Training of Cintia Piccina
| University of Sao Paulo | Doctorate Degree |
| Escola Superior de Propaganda e Marketing | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
- Stock Market
- Insiders
- Cintia Piccina